UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreductive Sur…
    David Bender
  2. Randomized, phase III, double-blind placebo-controlled trial of Sunitinib (NSC #736511, IND #74019) as maintenance therapy in non-progressing patients following an initial four cycles of platinum-base…
    Daniel Vaena
  3. Genetic Epidemiology of B-cell Lymphoproliferative Disorders; SPORE
    Brian Link
  4. A Randomized Trial of Pelvic Irradiation with or without Concurrent Weekly Cisplatin in Patients with Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
    David Bender
  5. Phase I/II Study Epigenetic Modification of Chemosensitivity and Apoptosis in Metastatic Melanoma: Treatment of a Resistant Disease Using Decitabine, Temozolomide and Panobinostat (55)
    Mohammed Milhem
  6. A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2 -Positive Ductal Carcinoma in Situ Resected by Lumpectomy
    Alexandra Thomas
  7. A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized P…
    Daniel Vaena
  8. A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103 (IND #70177), versus no Treatment until Documented Relapse in Women with Adva…
    David Bender
  9. Assessment of novel molecular markers in acute myeloid leukemia
    Daniel Vaena
  10. A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase II.5 Study of AZD0530, a Selective Src Kinase Inhibitor, In Patients with Recurrent Osteosarcoma Localized to the Lung (10)…
    Mohammed Milhem
  11. A Phase II Pilot Trial of Bortezomib (PS-341, VelcadeĀ®, IND# 58,443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic…
    Ayman El-Sheikh
  12. Rare and Cutaneous Non-Hodgkin Lymphoma Registry
    Ayman El-Sheikh
  13. RTOG 0920: A Phase III Study of postoperative radiation therapy (IMRT) +/- cetuximab for locally advanced resected head and neck cancer
    Mark C. Smith
  14. Randomized Phase III Clinical Trial of Adjuvant Radiation versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy
    David Bender
  15. A Phase III Prospective Randomized Trial Comparing Laparoscopic-assisted Resection Versus Open Resection for Rectal Cancer
    James Howe
  16. Treatment of Children with All Stages of Hepatoblastoma
    Ayman El-Sheikh
  17. Study to Test the Drug EGEN-001 in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer that has Re-Grown or not Responded after Prior Treatment
    David Bender
  18. Study for Women with Node-Positive or High Risk Node Negative HER2-Low Invasive Breast Cancer
    Mark Karwal
  19. Inflammation versus Tumor: Methods to Improve Accuracy of Post-Radiotherapy PET scans in Head and Neck Cancer Patients
    Carryn Anderson
  20. A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer
    Daniel Vaena

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.